SDPS-13 CELL LINE STUDY OF NUCLEOSOME-BASED BIOMARKERS IN THE DIAGNOSIS AND DETECTION OF RELAPSES IN GLIOBLASTOMA

Abstract Currently, glioblastoma (GBM) diagnosis and monitoring rely on neuroimaging and histopathological confirmation. However, overall survival has not improved in last decades due to therapeutic failure and to a lack of biomarkers for relapses’ detection. Liquid biopsies (i.e. blood or cerebrosp...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neuro-oncology advances 2023-08, Vol.5 (Supplement_3), p.iii19-iii19
Hauptverfasser:	Decarpentrie, Jonathan, Van den Ackerveken, Priscilla, Govaerts, Adrien, Lobbens, Alison, Beine, Edeline, Donis, Nathalie, Herzog, Marielle, Douxfils, Jonathan
Format:	Artikel
Sprache:	eng
Schlagworte:	Final Category: Screening/Diagnostics/Prognostics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!